Assembly Biosciences (ASMB) EBITDA Margin (QoQ) (2017 - 2026)
Assembly Biosciences (ASMB) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Assembly Biosciences | 282.74 Mn | 56.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,506.00 |
| Dec 31, 2025 | 14,749.00 |
| Sep 30, 2025 | 1,437.00 |
| Jun 30, 2025 | -970.00 |
| Mar 31, 2025 | 5,121.00 |
| Dec 31, 2024 | 331.00 |
| Sep 30, 2024 | -1,705.00 |
| Jun 30, 2024 | 4,245.00 |
| Mar 31, 2024 | -1,024.00 |
| Dec 31, 2020 | -381,115.00 |
| Sep 30, 2020 | -2,832.00 |
| Jun 30, 2020 | 69,532.00 |
| Mar 31, 2020 | -7,689.00 |
| Dec 31, 2019 | 1,263.00 |
| Sep 30, 2019 | 2,526.00 |
| Jun 30, 2019 | 8,976.00 |
| Mar 31, 2019 | -2,463.00 |
| Dec 31, 2018 | -17,802.00 |
| Sep 30, 2018 | 31,747.00 |
| Jun 30, 2018 | -37,653.00 |